Navigation Links
GlaxoSmithKline Update: Influenza A (H1N1)
Date:5/1/2009

LONDON and RESEARCH TRIANGLE PARK, N.C., May 1 /PRNewswire-FirstCall/ -- GlaxoSmithKline (NYSE: GSK) is committed to supporting governments and health authorities around the world to respond to the emergence of the new influenza A (H1N1) strain.

The company has developed a number of potential interventions which it believes may be of value in efforts to reduce the impact and spread of this new influenza virus. These include the antiviral medicine Relenza (zanamivir) and significant vaccine capability and technology, including use of novel adjuvants.

To ensure continuity of supply and manufacture of all its critical medicines and vaccines, GSK has also invoked its own internal pandemic preparedness plan.

Relenza (zanamivir)

GSK has been working with governments to supply Relenza, for use in a pandemic situation, since the global spread of avian influenza (H5N1) which began in 2003. Relenza has typically been used to diversify and add to government stockpiles of Tamiflu (oseltamivir).

Since 2003, Relenza has been supplied to 26 governments for the purposes of pandemic stockpiling and on average the product constituted 13% of these stockpiles. Prior to the recent outbreak, the last significant order for Relenza was for 10.6 million treatment packs, which was delivered to the UK Government in April 2009.

In relation to the new influenza A (H1N1) strain, the WHO reported that the viruses obtained from the recent human cases were sensitive to oseltamivir and zanamivir but resistant to amantadine and remantadine.(1)

GSK has therefore contacted governments around the world to ascertain demand for Relenza, including those countries most affected by the virus, such as Mexico and the USA. As a result, GSK
'/>"/>

SOURCE GlaxoSmithKline
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4

Related medicine news :

1. GlaxoSmithKline and Pfizer Announce Innovative Agreement to Create a New World-Leading, Specialist HIV Company
2. GlaxoSmithKline and Shire Enter Agreement to Co-Promote Vyvanse(R) (lisdexamfetamine dimesylate) CII for Adult Attention Deficit Hyperactivity Disorder
3. IADR and GlaxoSmithKline Consumer Healthcare announce winners of 2009 Innovation in Oral Care Awards
4. GlaxoSmithKline Consumer Healthcare to Reach 85 Percent of the Worlds Smokers with Quit Aids
5. GlaxoSmithKline Consumer Healthcare Helps to Bridge Oral Care Gap in Appalachia
6. Activplant Corporation Announces Global Agreement with GlaxoSmithKline
7. GlaxoSmithKline and Genmab Submit Arzerra(TM) (Ofatumumab) Application to FDA for the Treatment of Advanced Stage Blood Cancer
8. GlaxoSmithKlines Drug Will Become New Clinical Gold Standard by 2012 for the Treatment of Relapsed/Refractory CLL
9. GlaxoSmithKline Awards Ten Area Healthcare Nonprofits with $40,000 Each in Funding
10. GlaxoSmithKline and Dynavax Announce Worldwide Strategic Alliance : – Developing First-in-Class Endosomal TLR Inhibitors for Autoimmune and Inflammatory Diseases –
11. GlaxoSmithKline Statement on FDA Advisory Committee Vote on Use of Asthma Medicines Containing Long-Acting Beta-Agonists
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/21/2013)... May 21, 2013 Joe Vitale, a positive ... early adapter of the Fisker electric car. After a year ... since the car company went bankrupt, the bestselling author turned ... , "It's a gas guzzler's anthem," says Vitale, 59, ... album, "Sun Will Rise." , Owning this Fisker was ...
(Date:5/21/2013)... 21, 2013 Limited mobility affects ... Not only is it more difficult to walk around, but ... Fortunately, there are a variety of medical products made to ... product is the raised toilet seat. , Raised toilet ... easier to stand back up or sit down. They come ...
(Date:5/20/2013)... 2013 This week has been dedicated as ... (May 19th-May 25th) is an awareness campaign designated to help ... encouraging dog owners to properly train their pets, and educate ... dog bite lawyers at Buckfire & Buckfire, P.C. represent ... Michigan. The personal injury law firm is a large advocate ...
(Date:5/20/2013)... 2013 Recent environmental concerns have ... green and sustainable inputs in packaging products. As ... to promote the use of sustainable materials, thereby ... Services industry . “Tax subsidies and operating cost ... industry analyst Deonta Smith. “For example, many packaging ...
(Date:5/20/2013)... Daily Gossip, online magazine about lifestyle, health and sports issues, ... can help them overcome one of the most spread skin ... Vitiligo Treatment System has created a buzz on the ... from the persons who have tried it. Its principles have ... some of the people who tried it and managed to ...
Breaking Medicine News(10 mins):Health News:Upset Fisker Owner Records Gas Guzzler Anthem 2Health News:JustHomeMedical.com Launches Raised Toilet Seats Category 2Health News:Buckfire & Buckfire, P.C. Dog Bite Lawyers in Michigan Discuss National Dog Bite Prevention Week 2Health News:Packaging and Labelling Services in Canada Industry Market Research Report Now Available from IBISWorld 2Health News:Packaging and Labelling Services in Canada Industry Market Research Report Now Available from IBISWorld 3Health News:New Natural Vitiligo Treatment System That Helps People Treat Vitiligo Permanently Revealed by Daily Gossip Magazine 2
... Invasive plant species have long had a reputation as ... Stan Harpole, assistant professor of ecology, evolution and organismal ... team of more than 70 researchers working at 65 sites ... if it is true that problematic invasive species often spread ...
... CA (February 28, 2011) Eating more tomatoes and tomato ... of conditions such as cancer, osteoporosis and cardiovascular disease, ... of Lifestyle Medicine , (published by SAGE). Of ... tomato products than any others. Researchers Britt Burton-Freeman, PhD, ...
... -- For women with uterine fibroids, three treatments have ... improvements in quality of life, according to a new ... their childbearing years develop uterine fibroids, which are benign ... patients experience heavy bleeding, pain and infertility, according to ...
... SMOKING CESSATION HIGHER WITH VARENICLINE COMPARED WITH PLACEBO IN ... patients with chronic obstructive pulmonary disease (COPD) have higher ... a multinational study involving 27 centers, researchers from UCLA ... were randomized to receive either varenicline (N=250) or placebo ...
... for localized non-small cell lung cancers, may be unnecessary in ... published in the March issue of the Journal of ... Association for the Study of Lung Cancer. The risk ... a maximum standard uptake value (maxSUV) of 2.0 or a ...
... affect drug recommendations, with free journals positively recommending ... usually recommending against the use of the drugs, ... ( Canadian Medical Association Journal ) (pre-embargo link ... about corporate influence on educational medical journals, although ...
Cached Medicine News:Health News:Global ISU study: Invasive species widespread, but not more than at home range 2Health News:Health benefits of eating tomatoes emerge 2Health News:Uterine Fibroid Treatments Seem to Boost Quality of Life 2Health News:Journal 'Chest': News briefs from the March 2011 issue 2Health News:Lymph node dissection is not essential in small screen-detected lung cancers, new research shows 2Health News:The influence of advertising on drug recommendations 2
(Date:5/20/2013)... TAUNTON, Mass. , May 20, 2013 /PRNewswire/ ... Inc. ("OSI")  whose subsidiary companies include OMNIlife science®, ... experienced directors to their Board.  Guy ... serve as the Chairman of the Board of ... will join as a director. Before ...
(Date:5/20/2013)... LAVAL, Quebec , May 20, 2013  Valeant Pharmaceuticals ... announced members of its senior management team will make a ... Conference on Tuesday, June 11, 2013 at 9:20 a.m. PT. ... Los Angeles, CA. A ... available on the company,s Web site at www.valeant.com . ...
(Date:5/20/2013)... 20, 2013  Upsher-Smith Laboratories, Inc., a specialty ... treatments for diseases of the central nervous system, ... website, upsher-smith.com . The new site celebrates ... of the company,s mission statement – Advancing Pharmacotherapy, ... around people with a story to tell, a ...
Breaking Medicine Technology:Orthopaedic Synergy, Inc. Announces Key Additions to the Board of Directors 2Orthopaedic Synergy, Inc. Announces Key Additions to the Board of Directors 3Upsher-Smith Introduces Newly Redesigned Corporate Website 2
... Extremely accurate detections of ... well as glaucoma in ... be performed. Smooth operation ... perimetry. High accuracy of ...
... FDT is a breakthrough in visual field testing ... in pre-test. Introducing FDT, the first visual field ... enough to be used even in pre-test. Affordably ... trials behind it to validate performance. The instrument ...
... Matrix represents the latest breakthrough in ... technology, the Humphrey Matrix will help ... evaluation and assess treatment alternatives. Enhanced ... provide complete long-term glaucoma care for ...
... Exceptional comfort for those with ... Toric soft contact lenses let you enjoy ... other soft toric lensa difference youll especially ... throughout the day., This exceptional level of ...
Medicine Products: